IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

venBio Partners LLC

Q3 2025 Holdings

Filed 2025-11-14 | 6 holdings | $176.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pharvaris N V(PHVS)COMN69605108$115.8M4,639,30465.6%
Alumis Inc(ALMS)COM022307102$18.4M4,619,80310.4%
ALX Oncology Hldgs Inc(ALXO)COM00166B105$17.8M9,699,92510.1%
Harmony Biosciences Hldgs in(HRMY)COM413197104$13.5M489,1947.6%
Lyell Immunopharma Inc(LYEL)COM NEW55083R203$7.7M473,4794.4%
Artiva Biotherapeutics Inc(ARTV)COM04317A107$3.3M1,148,9751.9%